Plastic surgical management of skin cancer patients during the COVID-19 pandemic

Rich, Harvey; Jones, Beth A.; Malin, Ian; Hemington-Gorse, Sarah; Cubitt, Jonathan

doi:10.1016/j.bjps.2020.08.143

Cited by 8 publications

(14 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The abrupt arrival and spread of the COVID-19 pandemic continues to have profound impacts on healthcare delivery worldwide. [9][10][11][12][13][14][15][16] In Australia, the relatively low incidence of COVID-19 at that time is in part due to the stay-at-home orders and implementation of movement restrictions. Since the lockdown period between March and May 2020, resumption of elective surgery has been in an incremental and cautious manner.…”

Section: Discussionmentioning

confidence: 99%

“…Single institution studies in Europe, UK and the US noticed similar trends of a reduction in the diagnosis, surveillance and management of skin cancers by approximately 27-54 per cent. [10][11][12][13][14][15][16] These findings not only aid with predicting how future waves of COVID-19 may affect skin cancer management but will also assist in the development of strategies in the recovery phase.…”

Section: Discussionmentioning

confidence: 99%

“…Prioritising skin cancers also poses a dilemma as their aggressiveness is not always apparent in the first consultation. 10,15 A recent Cancer Australia publication showed that approximately one-third of general practice and specialist services attendances between April and June 2020 were by means of telehealth. 5 The majority of these services were delivered by telephone, with videoconferencing comprising of only 1-5 per cent of all consultations.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

The impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia

Sreedharan¹,

Sreedharan²,

Mian³

2022

Australas J Plast Surg

View full text Add to dashboard Cite

Introduction: The Australian healthcare system, including its management of cutaneous malignancies, has faced unprecedented challenges due to the COVID-19 pandemic. This study aimed to quantify the impact of the first wave of the pandemic on the diagnosis and management of cutaneous malignancies in Australia. Methods: Monthly service data was extracted from the Australian Medicare Benefits Schedule database for all cutaneous biopsies, non-melanotic skin cancer (NMSC) excisions and melanoma excisions performed between January 2017 and December 2019. Holt-Winters exponential smoothing forecasting models were developed for total biopsies, NMSC excisions and melanoma excisions. These models were used to predict monthly data between January 2020 and June 2020 with a 95 per cent confidence interval (p < 0.05). Absolute and percentage residual differences (RDs) between actual and predicted excisions for this time period were calculated. Results: There were statistically significant reductions in total NMSC excisions in March 2020 (RD: −6,943, −13.0%), April 2020 (RD: −8,954, −12.2%), May 2020 (RD: −17,667, −20.9%) and June 2020 (RD: −5,152, −6.9%). There were statistically significant reductions in melanoma excisions in April 2020 (RD: –695, –11.1%), May 2020 (RD: −1,982, –28.7%) and June 2020 (RD: –973, –16.0%). Conclusions: There was a significant reduction in skin cancer excisions in Australia during the COVID-19 pandemic. This observed reduction in skin cancer surgery has significant public health implications, highlighting the need for improved surveillance, diagnosis and treatment capacity of cutaneous malignancies during the recovery phase of the pandemic.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia

Sreedharan¹,

Sreedharan²,

Mian³

2022

Australas J Plast Surg

View full text Add to dashboard Cite

show abstract

“…COVID-19 pandemijos metu plačiai paplito nuotolinės konsultacijos, telemedicina odos ligų gydytojų praktikoje, tačiau kilus bent mažiausiam piktybinio naviko, ypač melanomos įtarimui, turi būti kontaktinė dermatologo konsultacija dėl gydymo, jei reikia, stacionarinio ir operacinio [16,17].…”

Section: įVadasunclassified

Covid-19 Pandemijos Poveikis Sergančiųjų Melanoma Hospitaliniam Prieinamumui: Patirtis

Janušonytė¹,

Janušonis²,

Kasap³

2021

Health Sciences

View full text Add to dashboard Cite

COVID-19 pandemija sutrikdė ir apribojo visą sveikatos priežiūrą, ypač planinę, tarp jos onkologinę pagalbą, o kartu ir pagalbą sergantiems melanoma. Darbo tikslas – ištirti ir palyginti pacientų, sergančių melanoma, stacionarinės medicinos pagalbos prieinamumą iki COVID-19 pandemijos (2019) ir pandemijos (2020) metais. Analizuotos įvairių šalių autorių mokslinės publikacijos nagrinėjama tema, tirtos melanoma sirgusių pacientų ligos istorijos. Straipsnyje atskleisti pacientų, sirgusių melanoma ir hospitalizuotų abiem tirtais periodais, sveikatos priežiūros prieinamumo skirtumai ir priežastys. Nustatyta, kad sergančiųjų melanoma hospitalinis prieinamumas pandemijos metais buvo kiek sutrikęs, tačiau reikiama medicinos pagalba, tarp jos ir planinė, buvo teikiama.

show abstract

“…Anticipating complete redeployment of our staff and the inability to operate, we acted early and prioritized urgent skin cancer cases as early diagnosis and treatment is important for maximizing survival outcomes 6 . On the other hand, it is difficult to evaluate and prioritize skin malignancies because skin cancer ranges from slowly progressing types that can be monitored, to very aggressive forms that progress rapidly.…”

Section: Introductionmentioning

confidence: 99%

Skin cancer surgery at the time of the covid-19 pandemic: A single center experience

Samara

Ameerally

2021

Advances in Oral and Maxillofacial Surgery

View full text Add to dashboard Cite

Elective operations were significantly reduced in order to eliminate, as much as possible, the risks of SARS -CoV-2 virus infection for both patients and medical personnel and to leave the clinical facilities and intensive care available for access to COVID patients. We looked at the total number of patients treated for skin cancer surgery at both hospitals from the 23rd of March 2020 till the 28th of May 2020, the demographic characteristics, the medical comorbidities, the pathologies operated on in day surgery regimens of care and the surgical outcomes. With regards to the site, more than one third of the patients were treated at a private hospital setting. Among the surgery complications identified there was one graft failure following excision of scalp lesion which histology confirmed regressed keratoacanthoma. Moreover, three infections associated with the lesions excised occurred and were treated with antibiotics. With regards to morbidity there was only one covid-19 infection among the patients that attended for skin cancer surgery and two deaths. The utilization of Covid-free locations, other than NHS hospitals, for elective surgery improved the efficiency of the service and together with the practical steps in theatre management and minimizing footfall, allowed the successful continuation of care during the pandemic.

show abstract

Plastic surgical management of skin cancer patients during the COVID-19 pandemic

Cited by 8 publications

References 0 publications

The impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia

The impact of the COVID-19 pandemic on management of cutaneous malignancies in Australia

Covid-19 Pandemijos Poveikis Sergančiųjų Melanoma Hospitaliniam Prieinamumui: Patirtis

Skin cancer surgery at the time of the covid-19 pandemic: A single center experience

Contact Info

Product

Resources

About